Founded in 1897 in Gampel, Lonza takes its name from the nearby river and initially produced electricity to manufacture chemicals such as calcium carbide.

Today Lonza develops and manufactures medicines for clinical and commercial stages and across modalities, from small molecules to biologics including antibodies and cell and gene therapies.

Lonza offers customers advanced manufacturing and quality-control systems, superior regulatory expertise, strong R&D capabilities and world class facilities in more than 30 countries.

Award
  • Nominated in 2020